RVL Pharmaceuticals plc Contract with Customer, Refund Liability, Current
RVL Pharmaceuticals plc had Contract with Customer, Refund Liability, Current of $19.70 million as of 2021-03-31, per its 10-Q filed 2021-05-13.
Discontinued › Notes
us-gaap:ContractWithCustomerRefundLiabilityCurrent · last filed 2022-03-30
- 2021-03-31: Contract with Customer, Refund Liability, Current $19.70M.
- 2020-12-31: Contract with Customer, Refund Liability, Current $88.00K; Contract with Customer, Refund Liability, Current as first filed $22.03M.
- 2020-09-30: Contract with Customer, Refund Liability, Current $22.60M.
- 2020-06-30: Contract with Customer, Refund Liability, Current $25.98M.
| Period end | Contract with Customer, Refund Liability, Current | Contract with Customer, Refund Liability, Current as first filed |
|---|---|---|
| 2021-03-31 | $19.70M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $88.00K 10-K · filed 2022-03-30 | $22.03M 10-K · filed 2021-03-30 |
| 2020-09-30 | $22.60M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $25.98M 10-Q · filed 2020-08-11 | |
| 2020-03-31 | $29.20M 10-Q · filed 2020-05-12 | |
| 2019-12-31 | $55.00K 8-K · filed 2021-09-08 | $33.46M 10-K · filed 2020-03-19 |
| 2019-09-30 | $38.18M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $47.13M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $45.71M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $48.46M 10-K · filed 2020-03-19 | $48.46M 10-K · filed 2019-03-28 |
| 2018-09-30 | $44.63M 10-Q · filed 2018-11-08 | |
| 2017-12-31 | $43.30M 8-K · filed 2019-12-20 |